Top 5 AANP 2021 Presentations
NP expert reviews the top 5 most practical presentations from AANP 2021 with topics ranging from obesity medications and suicide prevention to managing hypertension in diverse populations and cannabinoid use.
Bipolar Disorders
Case Studies Demonstrate Promise for Electroconvulsive Therapy
ECT treatments helped to reduce symptoms in 4 patients with varying mental illnesses.
No Increase in Treatment-Emergent Mania With Lurasidone for Bipolar Depression
Researchers assessed data from short-term studies with open-label extensions among adults and adolescents with bipolar depression to assess the impact of lurasidone on treatment-emergent mania.
Screening Tool Effective for Identifying Bipolar I Disorder During a Depressive Episode
Investigators conducted a comprehensive literature search to identify key characteristics that best differentiate between bipolar I disorder and major depressive disorder.
Characteristics Associated with Length of Hospital Stay in Patients With Bipolar Disorder
Investigators sought to identify characteristics associated with length of hospital stay in individuals undergoing electroconvulsive therapy for bipolar disorder.
Weight Gain, Treatment Interruptions Reported With Second-Generation Antipsychotics for Schizophrenia, Bipolar 1 Disorder
Research was conducted to assess the impact of initiation of treatment with second-generation antipsychotics and treatment interruptions on weight gain in patients with schizophrenia and bipolar 1 disorder.
Familial Psychiatric History Common in Bipolar Disorder
Outpatients with bipolar disorder often have familial psychiatric history, which is associated with disease severity and sociodemographic measures,
Mood Disorders With HIV Increase Risk for Noncommunicable Disease
Focused prevention and treatment of noncommunicable diseases may reduce the burden of multimorbidity in people living with HIV who have mood disorders and multimorbidity.
Family Therapy Aids Youth at High Risk for Bipolar Disorder
Times between mood episodes longer for those in family-focused therapy vs enhanced usual care.
Relapse More Likely With Antipsychotic Switch in Schizophrenia, Bipolar Disorder, or MDD
Patients with schizophrenia or a mood disorder who switched antipsychotic treatment had an increased likelihood for relapse, healthcare resource utilization, and extrapyramidal symptoms.
- Loading...
Loading...
Next post in Mood Disorder Information Center
Loading... 
Loading...